Icu Medical (ICUI) Stock
Infusion therapy systems and hospital consumable supplier. Here's the price, business snapshot, and what's worth knowing about Icu Medical in October 2026.
ICU Medical Inc (ICUI) is a US-based medical device company that designs, manufactures and sells infusion therapy systems, vascular access devices and related consumables for hospitals and clinics. Investors should note that the business model combines durable capital equipment with recurring revenue from single-use disposables, which can support steady cash flows but is exposed to hospital purchasing cycles and reimbursement dynamics. Growth drivers include new product introductions, replacement demand, aftermarket consumables and selective acquisitions, while risks include regulatory approvals, competitive pressure from larger med-tech peers and possible margin volatility. The company operates in a highly regulated sector where quality and compliance are critical. Financial strength, pricing power and a stable installed base are key metrics to watch. This is general educational information, not personal financial advice — values can rise and fall and past performance is not a guide to future returns.
Icu Medical (ICUI) Stock Forecast
Analyst price target, next 12 months
$175.00
+5.0% vs today's $166.62
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Icu Medical have a consensus 12-month target of $175.00, above the current price of $166.62.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 26 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying ICU Medical's stock with a target price of $175, indicating growth potential.
Financial Health
ICU Medical is performing well, showing strong revenue, cash flow, and a solid profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Recurring consumable revenue
A steady stream of single‑use supplies can support predictable sales, though hospital purchasing cycles and pricing pressure may affect growth.
Regulatory and quality focus
Product approvals and compliance are essential in med‑tech; regulatory outcomes can materially influence performance and costs.
Market position and growth
New product launches and selective acquisitions can expand reach internationally, but competition from larger peers remains a consideration.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
